12 results
8-K
EX-10.2
ARVN
Arvinas Inc
27 Nov 23
Arvinas Announces Oversubscribed $350 Million Private Placement
7:11am
or plaintiff to such indemnified party of a release from all liability in respect of such claim or litigation.
(d) Contribution. If for any reason
8-K
EX-10.1
ARVN
Arvinas Inc
27 Nov 23
Arvinas Announces Oversubscribed $350 Million Private Placement
7:11am
by the claimant or plaintiff to such indemnified party of a release from all liability in respect of such claim or litigation. No indemnified party
S-3ASR
EX-1.2
ARVN
Arvinas Inc
7 Nov 23
Automatic shelf registration
5:24pm
with such consent or if there be a final judgment for the plaintiff, the indemnifying party agrees to indemnify the indemnified party against any loss
8-K
EX-1.1
ARVN
Arvinas Inc
6 Aug 21
Entry into a Material Definitive Agreement
4:09pm
judgment for the plaintiff, the indemnifying party agrees to indemnify the indemnified party against any loss, claim, damage, liability or expense
8-K
EX-10.1
cwf8xmba6p1 wr
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein
7:30am
10-K
EX-4.2
o5k68kd7rqnpv0
26 Mar 19
Annual report
4:31pm
DRS/A
EX-3.1
yw9zte8ya5
2 Aug 18
Draft registration statement (amended)
12:00am
DRS
EX-10.7
umz8lt f1wg6fq1783
22 Jun 18
Draft registration statement
12:00am
DRS
EX-3.1
5fsin2
22 Jun 18
Draft registration statement
12:00am
- Prev
- 1
- Next